OBJECTIVE: To evaluate the effect of tubes mixing (gentle vs. vigorous) on diagnostic blood specimens collected in vacuum tube systems by venipuncture. DESIGN AND METHODS: Blood was collected for routine coagulation, immunochemistry and hematological testing from one hundred volunteers into six vacuum tubes: two 3.6 mL vacuum tubes containing 0.4 mL of buffered sodium citrate (9NC) 0.109 mol/L: 3.2 W/V%; two 3.5 mL vacuum tubes with clot activator and gel separator; and two 3.0 mL vacuum tubes containing 5.9 mg K(2)EDTA (Terumo Europe, Belgium). Immediately after the venipuncture all vacuum tubes (each of one additive type) were processed through two different procedures: i) Standard: blood specimens in K(2)EDTA- or sodium citrate-vacuum tubes were gently inverted five times whereas the specimens in tubes with clot activator and gel separator were gently inverted ten times, as recommended by the manufacturer; ii) Vigorous mix: all blood specimens were shaken up vigorously during 3-5s independently of the additive type inside the tubes. The significance of the differences between samples was assessed by Student's t-test or Wilcoxon ranked-pairs test after checking for normality. The level of statistical significance was set at P<0.05. RESULTS: No significant difference (P<0.05) was detected between the procedures for all tested parameters. Surprisingly only a visual alteration (presence of foam on the top) was shown by all the tubes mixed vigorously before centrifugation (Fig. 1 A, B and C). Moreover the serum tubes from vigorous mixing procedure shows a "blood ring" on the tube top after stopper removal (Fig. 1 D). CONCLUSION: Our results drop out a paradigm suggesting that the incorrect primary blood tubes mixing promotes laboratory variability. We suggest that similar evaluation should be done using other brands of vacuum tubes by each laboratory manager.
OBJECTIVE: To evaluate the effect of tubes mixing (gentle vs. vigorous) on diagnostic blood specimens collected in vacuum tube systems by venipuncture. DESIGN AND METHODS: Blood was collected for routine coagulation, immunochemistry and hematological testing from one hundred volunteers into six vacuum tubes: two 3.6 mL vacuum tubes containing 0.4 mL of buffered sodium citrate (9NC) 0.109 mol/L: 3.2 W/V%; two 3.5 mL vacuum tubes with clot activator and gel separator; and two 3.0 mL vacuum tubes containing 5.9 mg K(2)EDTA (Terumo Europe, Belgium). Immediately after the venipuncture all vacuum tubes (each of one additive type) were processed through two different procedures: i) Standard: blood specimens in K(2)EDTA- or sodium citrate-vacuum tubes were gently inverted five times whereas the specimens in tubes with clot activator and gel separator were gently inverted ten times, as recommended by the manufacturer; ii) Vigorous mix: all blood specimens were shaken up vigorously during 3-5s independently of the additive type inside the tubes. The significance of the differences between samples was assessed by Student's t-test or Wilcoxon ranked-pairs test after checking for normality. The level of statistical significance was set at P<0.05. RESULTS: No significant difference (P<0.05) was detected between the procedures for all tested parameters. Surprisingly only a visual alteration (presence of foam on the top) was shown by all the tubes mixed vigorously before centrifugation (Fig. 1 A, B and C). Moreover the serum tubes from vigorous mixing procedure shows a "blood ring" on the tube top after stopper removal (Fig. 1 D). CONCLUSION: Our results drop out a paradigm suggesting that the incorrect primary blood tubes mixing promotes laboratory variability. We suggest that similar evaluation should be done using other brands of vacuum tubes by each laboratory manager.
Authors: Gabriel Lima-Oliveira; Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Geraldo Picheth; Gian Cesare Guidi Journal: Indian J Clin Biochem Date: 2013-04-03
Authors: Robert C Gosselin; Annette Bowyer; Emmanuel J Favaloro; Jill M Johnsen; Giuseppe Lippi; Richard A Marlar; Keith Neeves; Marian A Rollins-Raval Journal: J Thromb Haemost Date: 2021-09-02 Impact factor: 16.036
Authors: Gabriel Lima-Oliveira; Gian Luca Salvagno; Giuseppe Lippi; Elisa Danese; Matteo Gelati; Martina Montagnana; Geraldo Picheth; Gian Cesare Guidi Journal: Biochem Med (Zagreb) Date: 2014-10-15 Impact factor: 2.313
Authors: Gabriel Lima-Oliveira; Giuseppe Lippi; Gian Luca Salvagno; Geraldo Picheth; Gian Cesare Guidi Journal: J Med Biochem Date: 2015-07-14 Impact factor: 3.402
Authors: Gabriel Lima-Oliveira; Gian Cesare Guidi; Andre Valpassos Pacifici Guimaraes; Jose Abol Correa; Giuseppe Lippi Journal: J Med Biochem Date: 2017-01-25 Impact factor: 3.402
Authors: Gabriel Lima-Oliveira; Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Geraldo Picheth; Gian Cesare Guidi Journal: Biochem Med (Zagreb) Date: 2013 Impact factor: 2.313
Authors: Karin Bölenius; Marie Lindkvist; Christine Brulin; Kjell Grankvist; Karin Nilsson; Johan Söderberg Journal: BMC Health Serv Res Date: 2013-11-05 Impact factor: 2.655